Hospital News
Return to Urologic Cancer Overview
More on Urologic Cancer
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma
- Coping With Chronic Cancer Pain
- Do Heart Disease and Cancer Have a Common Genetic Link?
- Health Effects of Secondhand Smoke Studied in First-of-Its-Kind Series of Clinical Studies
- Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
- Message to the Elderly: It's Never Too Late to Prevent Illness!
- New Book by Weill Cornell Psychiatrist Offers Insight and Hope for "Surviving Cancer Emotionally"
- NewYork-Presbyterian/Weill Cornell Creates World-Class Cancer Center
- NewYork-Presbyterian Hospital's Weill Cornell Medical Center Announces Preliminary Lung Cancer Data Involving Patients Treated With Arthritis Medication
- Robotic Prostate Surgery Study Finds 5-Year Outcomes Favorable
- Study Looks at New Bladder Cancer Therapy for Patients Unresponsive to Standard Treatment
- The Seventh Issue of Cancer Prevention Has Arrived!
- Tumor Size Predicts Survival in Most Common Type of Lung Cancer
- Two Novel Biologics Studied for Multiple Myeloma
Health Library
Return to Urologic Cancer Overview
More on Urologic Cancer
- Bladder Cancer
- Cancer: Overview of Diagnostic Procedures
- Cancer Overview
- Cancer Rehabilitation
- Cancer Treatment Protocols
- Grading and Staging of Cancer
- Immunotherapy (Biological Therapy)
- Kidney Cancer
- Penile Cancer
- Prostate Cancer
- Prostate Cancer: Clinical Trials
- Prostate Cancer: Expectant Therapy
- Prostate Cancer: Psychosocial Factors
- Prostate Cancer: Stages
- Prostate Cancer Grading
- Prostate Cancer in African-American Men
- Prostate Cancer Risk Factors
- Prostate Cancer Signs and Symptoms
- Prostate Cancer Statistics
- Prostate Problems: Diagnostic and Evaluation Procedures
- Prostate Surgery
- Radiation Oncology
- Radiation Oncology: Promising New Therapies
- Radiation Therapy
- Testicular Cancer
Clinical Services
Return to Urologic Cancer Overview
More on Urologic Cancer
- Bladder Cancer
- Blood Cancer
- Brain Cancer
- Center for Holistic Urology
- Center for Lymphoma and Myeloma
- Colon Cancer
- Early Lung Cancer Action Program
- Edward S. Harkness Eye Institute
- Esophageal Cancer
- Eye Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Head and Neck Cancer
- Kidney Cancer
- Leukemia and Myeloproliferative Disease Center
- Liver Cancer
- Lung Cancer
- Mesothelioma
- Oncology (Cancer)
- Pancreatic and Biliary Cancer
- Pediatric Cancer
- Prostate Cancer
- Rectal Cancer
- Robert M. Ellsworth Ophthalmic Oncology Center
- Soft Tissue and Bone Cancer
- Spirit of Care Program
- Stomach Cancer
- Testicular Cancer
Urologic Cancer
The mission of the Genitourinary Oncology Program of the NewYork-Presbyterian Cancer Centers is to provide a comprehensive multidisciplinary approach to the management of genitourinary malignancies. Dedicated to groundbreaking basic urologic oncology research, the Cancer Centers have made extraordinary advances in the understanding of prostate, bladder, kidney, and testicular cancers and have translated these advances into state-of-the-art diagnostic and treatment approaches. Specialists representing urology, medical oncology, surgery, pathology, and radiation oncology collaborate closely, conducting clinical trials for all stages of genitourinary cancers and pursuing research aimed at developing new preventive, early screening, and therapeutic modalities. By combining world-class research, sophisticated diagnostics, outstanding teamwork, and the newest treatment options, patients receive the highest level of care for these cancers.
Hospital News
- Bexxar Effective as First-Line Treatment for Non-Hodgkin's Lymphoma Patients When Used With Chemotherapy
- Cancer Treatment Is First to Directly Target Tumor Blood Supply in Patients
- Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody Effective in Previously Untreated Non-Hodgkin's Lymphoma More
Clinical Services
RELATED LINKS
- Radiation Oncology, NewYork-Presbyterian/Columbia
- Radiation Oncology, NewYork-Presbyterian/Weill Cornell
- Hematology/Oncology, NewYork-Presbyterian/Columbia
- Hematology and Medical Oncology, NewYork-Presbyterian/Weill Cornell
- Urology, NewYork-Presbyterian/Columbia
- Urology, NewYork-Presbyterian/Weill Cornell
- Robotic Prostate Surgery, NewYork-Presbyterian/Columbia
- Robotic Prostate Surgery, NewYork-Presbyterian/Weill Cornell
- Herbert Irving Comprehensive Cancer Center
- Weill Cornell Comprehensive Cancer Care and Blood Disorders
- Center for Holistic Urology, NewYork-Presbyterian/Columbia
